Brewin Dolphin Podcast
Latest Episodes
Podcast Macro Special
A dedicated macro economic podcast with Brewin’s Head of Research, Guy Foster.     The value of investments can fall and you may get back less than you invested. Past performance is not a guide to future performance. All information withi
The ECB Takes Centre Stage
A discussion of the ECB’s raft of new policy measures, as well as closer look into Tesco and Vodafone’s prospects.     The value of investments can fall and you may get back less than you invested. Past performance is not a guide to futu
Sell in May? Not this year!
A monthly round up of global stock market performance, followed up by a closer look at the Mining and Life Insurance sectors. Â Â Â Â The value of investments can fall and you may get back less than you invested. Past performance is not a guide
Interesting moves in UK Pharma
Our thoughts on the latest economic data emanating from the UK and Europe, an update on the Pfizer/Astra deal, and some interesting moves at BTG. Â Â Â The value of investments can fall and you may get back less than you invested. Past performance
Supermarkets, SAGA and the economy
An update on the supermarket price war from Podcast debutant Nicla Di Palma, some further thoughts on the SAGA IPO, and the major economic news of the week. Â Â Â The value of investments can fall and you may get back less than you invested. Past
Podcast #28 - Weekly Market Update
The Brewin Dolphin Research Team provide their latest thoughts on the week’s major economic and corporate developments. In this edition we discuss the performance and progress of the UK banking sector, as well as a review of recent data out of the UK, E
Welcome to the Yield
Ben Gutteridge - Head of Fund Research invites Equity Analyst, James Hay to discuss AstraZeneca rejection of Pfizer’s takeover offer and Equity Analyst Nik Stanojevic to talk about the Telecoms sector. Ben also provides an update of the week’s events
Renaissance Men
Back from their Easter breaks and with so much news to cover that the team have enlisted the help of James Hay - Equity Analyst to discuss the health care sector. Regular contributors Ben Gutteridge – Head of Fund Research, Guy Foster – Head of Resear